Literature DB >> 11979551

Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell lines.

Hiroyuki Tagawa1, Ikuo Miura, Ritsuro Suzuki, Hiroko Suzuki, Yoshitaka Hosokawa, Masao Seto.   

Abstract

Chromosome band 6q21 is reported to be one of the most frequent target regions in T-cell lymphoma for both translocations and deletions. To explore whether the breakpoint clustering in T-cell malignancy indicates the presence of a common breakpoint region in 6q, we employed fluorescence in situ hybridization analysis using various YAC, BAC, and PAC clones aligned at 6q21-22. We identified two T-cell lymphoma/leukemia cell lines with different differentiation stages that had breakpoints within the same novel gene, TCBA1 (T-cell lymphoma breakpoint associated target 1). In a T-cell lymphoblastic lymphoma cell line, HT-1, the TCBA1 fused to SUSP1 (SUMO-1-specific protease), creating a SUSP1-TCBA1 chimeric gene. However, in an adult T-cell leukemia cell line, ATN-1, no chimeric gene was detected, although aberrant TCBA1 transcripts were produced. We conclude that TCBA1 is a possible target gene for T-cell lineage-specific chromosome aberrations at 6q21. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979551     DOI: 10.1002/gcc.10057

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Evidence for large inversion polymorphisms in the human genome from HapMap data.

Authors:  Vikas Bansal; Ali Bashir; Vineet Bafna
Journal:  Genome Res       Date:  2006-12-21       Impact factor: 9.043

Review 2.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

3.  Disruption of TCBA1 associated with a de novo t(1;6)(q32.2;q22.3) presenting in a child with developmental delay and recurrent infections.

Authors:  Y Yue; K Stout; B Grossmann; U Zechner; A Brinckmann; C White; D T Pilz; T Haaf
Journal:  J Med Genet       Date:  2005-05-20       Impact factor: 6.318

4.  Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer.

Authors:  Xueying Mao; Lara K Boyd; Rafael J Yáñez-Muñoz; Tracy Chaplin; Liyan Xue; Dongmei Lin; Ling Shan; Daniel M Berney; Bryan D Young; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2011-04-15       Impact factor: 6.166

Review 5.  The structure and function of NKAIN2-a candidate tumor suppressor.

Authors:  Shan-Chao Zhao; Bo-Wei Zhou; Fei Luo; Xueying Mao; Yong-Jie Lu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  A high-resolution integrated map of copy number polymorphisms within and between breeds of the modern domesticated dog.

Authors:  Thomas J Nicholas; Carl Baker; Evan E Eichler; Joshua M Akey
Journal:  BMC Genomics       Date:  2011-08-16       Impact factor: 3.969

7.  Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL.

Authors:  Luciana M Fontanari Krause; Anna Sophia Japp; Alexandre Krause; Jana Mooster; Martin Chopra; Markus Müschen; Stefan K Bohlander
Journal:  Sci Rep       Date:  2014-10-09       Impact factor: 4.379

8.  Molecular hallmarks of adult T cell leukemia.

Authors:  Makoto Yamagishi; Toshiki Watanabe
Journal:  Front Microbiol       Date:  2012-09-17       Impact factor: 5.640

9.  NKAIN2 functions as a novel tumor suppressor in prostate cancer.

Authors:  Xueying Mao; Fei Luo; Lara K Boyd; Bowei Zhou; Yanling Zhang; Elzbieta Stankiewicz; Jacek Marzec; Natasa Vasiljevic; Yongwei Yu; Ninghan Feng; Jia Xu; Attila Lorincz; Yong Jiang; Claude Chelala; Guoping Ren; Daniel M Berney; Shan-Chao Zhao; Yong-Jie Lu
Journal:  Oncotarget       Date:  2016-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.